目次

Table of Contents

1. Immuno-Oncology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type
6.3. Segmentation By Therapeutic Application
6.4. Segmentation By End Users

7. Immuno-Oncology Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type
7.2.1. Immune Checkpoint Inhibitors
7.2.2. Immune System Modulators
7.2.3. Other Monoclonal Antibodies
7.2.4. Cancer Vaccines
7.2.5. Others
7.3. Market Segmentation By Therapeutic Application
7.3.1. Melanoma
7.3.2. Lung Cancer
7.3.3. Blood Cancer
7.3.4. Renal Cell Carcinoma
7.3.5. Prostate Cancer
7.3.6. Bladder Cancer
7.3.7. Others
7.4. Market Segmentation By End User
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Ambulatory Surgical Centers
7.4.4. Cancer Research Institutes

8. Immuno-Oncology Drugs Market Trends and Strategies
8.1. Increasing Usage of Microneedle Pills
8.2. Development Of Personalized Cancer Vaccines
8.3. Increase In Acquisition Activity Among Immuno-Oncology Drug Market Players
8.4. Development And Increasing Demand For Next-Generation Biologics
8.5. Investment In Artificial Intelligence For Oncology Drugs
8.6. Use Of 3D Printing To Test New Oncology Drugs
8.7. Immuno-Oncology Combination Therapies
8.8. CAR-T Cell Therapy

9. COVID Impact On The Immuno-Oncology Drugs Market
9.1. COVID-19 Pandemic Effects On Cancer Patients and Survivors
9.2. Clinical Trial Delays
9.3. Low Usage Of Drugs
9.4. Supply Chain Issues
9.5. Future Outlook

10. Global Immuno-Oncology Drugs Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
10.2.1. Drivers Of The Market 2016-2021
10.2.2. Restraints On The Market 2016 - 2021
10.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
10.3.1. Drivers Of The Market 2021 - 2026
10.3.2. Restraints On The Market 2021 - 2026

11. Global Immuno-Oncology Drugs Market Segmentation
11.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.3. Global Immuno-Oncology Drugs Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Immuno-Oncology Drugs Market, Regional And Country Analysis
12.1. Global Immuno-Oncology Drugs Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Immuno-Oncology Drugs Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Asia-Pacific Immuno-Oncology Drugs Market
13.1. Asia-Pacific Immuno-Oncology Drugs Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.3. Asia-Pacific Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.4. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.5. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Asia-Pacific Immuno-Oncology Drugs Market: Country Analysis
13.7. China Immuno-Oncology Drugs Market
13.8. China Immuno-Oncology Drugs Market Overview
13.8.1. Region Information
13.8.2. Market Information
13.8.3. Background Information
13.8.4. Government Initiatives
13.8.5. Regulations
13.8.6. Regulatory Bodies
13.8.7. Major Associations
13.8.8. Taxes Levied
13.8.9. Corporate Tax Structure
13.8.10. Investments
13.8.11. Major Companies
13.9. China Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.10. China Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.11. China Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.12. China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. India Immuno-Oncology Drugs Market
13.14. India Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.15. India Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.16. India Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.17. India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.18. Japan Immuno-Oncology Drugs Market
13.19. Japan Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.20. Japan Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.21. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.22. Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.23. Australia Immuno-Oncology Drugs Market
13.24. Australia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.25. Australia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.26. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.27. Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.28. Indonesia Immuno-Oncology Drugs Market
13.29. Indonesia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.30. Indonesia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.31. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.32. Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.33. South Korea Immuno-Oncology Drugs Market
13.34. South Korea Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.35. South Korea Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.36. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.37. South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. Western Europe Immuno-Oncology Drugs Market
14.1. Western Europe Immuno-Oncology Drugs Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.3. Western Europe Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.4. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.5. Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. Western Europe Immuno-Oncology Drugs Market: Country Analysis
14.7. UK Immuno-Oncology Drugs Market
14.8. UK Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.9. UK Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.10. UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.11. UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.12. Germany Immuno-Oncology Drugs Market
14.13. Germany Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.14. Germany Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.15. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.17. France Immuno-Oncology Drugs Market
14.18. France Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.19. France Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.20. France Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.21. France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. Eastern Europe Immuno-Oncology Drugs Market
15.1. Eastern Europe Immuno-Oncology Drugs Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.3. Eastern Europe Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.4. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.5. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. Eastern Europe Immuno-Oncology Drugs Market: Country Analysis
15.7. Russia Immuno-Oncology Drugs Market
15.8. Russia Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.9. Russia Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.10. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.11. Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. North America Immuno-Oncology Drugs Market
16.1. North America Immuno-Oncology Drugs Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate Tax Structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.3. North America Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.4. North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.5. North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. North America Immuno-Oncology Drugs Market: Country Analysis
16.7. USA Immuno-Oncology Drugs Market
16.8. USA Immuno-Oncology Drugs Market Overview
16.8.1. Region Information
16.8.2. Market Information
16.8.3. Background Information
16.8.4. Government Initiatives
16.8.5. Regulations
16.8.6. Regulatory Bodies
16.8.7. Major Associations
16.8.8. Taxes Levied
16.8.9. Corporate Tax Structure
16.8.10. Investments
16.8.11. Major Companies
16.9. USA Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.10. USA Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.11. USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.12. USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. South America Immuno-Oncology Drugs Market
17.1. South America Immuno-Oncology Drugs Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.3. South America Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.4. South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.5. South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. South America Immuno-Oncology Drugs Market: Country Analysis
17.7. Brazil Immuno-Oncology Drugs Market
17.8. Brazil Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.9. Brazil Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.10. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.11. Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Middle East Immuno-Oncology Drugs Market
18.1. Middle East Immuno-Oncology Drugs Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.3. Middle East Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.4. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.5. Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

19. Africa Immuno-Oncology Drugs Market
19.1. Africa Immuno-Oncology Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Immuno-Oncology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.3. Africa Immuno-Oncology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.4. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.5. Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

20. Global Immuno-Oncology Drugs Market Competitive Landscape
20.1. Company Profiles
20.2. F. Hoffmann-La Roche Ltd. (Roche)
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Merck & Co.
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Bristol-Myers Squibb Company
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Amgen Inc
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Johnson & Johnson (J&J)
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market
21.1. Sanofi Acquired Amunix Pharmaceuticals Inc.
21.2. Takeda Yet To Acquire Adaptate Biotherapeutics
21.3. Takeda Acquired GammaDelta Therapeutics
21.4. Pfizer Acquired Trillium Therapeutics
21.5. Amgen Acquired Teneobio Inc.
21.6. True North Acquired Stake In Biocon Biologics Ltd.
21.7. PAG Acquired Stake In Hisun BioRay
21.8. Eli Lilly And Company Acquired Loxo Oncology, Inc.
21.9. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech
21.10. Bristol-Myers Squibb Acquired Celgene Corporation
21.11. Kashiv Pharma, LLC Acquired Adello Biologics
21.12. Takeda Pharmaceutical Company Limited Acquired Shire Plc
21.13. GlaxoSmithKline Plc Acquired Tesaro Inc.

22. Immuno-Oncology Drugs Market Opportunities And Strategies
22.1. Global Immuno-Oncology Drugs Market In 2026 - Countries Offering Most New Opportunities
22.2. Global Immuno-Oncology Drugs Market In 2026 - Segments Offering Most New Opportunities
22.3. Global Immuno-Oncology Drugs Market In 2026 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Immuno-Oncology Drugs Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer
24.7.